Shalby Ltd

Governance / Compliance

• CMHO directed suspension of Shalby Hospital, Jabalpur registration pending safety-report submission.
• Minor fire incident on Oct 11, 2026; no injuries and patients shifted.
• Reassessment of fire and electrical safety audits underway; reports to be submitted promptly.
• Suspension restricts new admissions; arrangements made for existing patients.

Shalby Limited trading window closed from Oct 01, 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended Sept 30, 2026; re-open thereafter

Cessation of Shanay Vikram Shah (AD/WTD)

• Shanay Vikram Shah ceased as Additional Director and Whole-Time Director effective 10 September 2026.
• Reason: AGM voting did not secure majority; remains President of the Company.
• Tenure: Aug 12, 2026 to 10 Sep 2026 as Additional Director/WTD.
• Impact: WTD position vacated; Presidency continues.
• No disclosure of other listed directorships or committee roles.

AGM Details

• AGM held on 10 September 2026 at 4:00 PM via Video Conferencing.
• Remote e-voting before and during AGM; Scrutinizer appointed for process.
• Voting rights reckoned as of cut-off date 3 September 2026.

Key Resolutions

• Resolution 1 (Ordinary): Adoption of audited standalone and consolidated financial statements; passed.
• Resolution 2 (Ordinary): Ratification of remuneration payable to Cost Auditors; passed.
• Resolution 3 (Ordinary): Appointment of Mr. Shanay Shah as Director; not passed.
• Resolution 4 (Ordinary): Appointment of Mr. Shanay Vikram Shah as Whole-Time Director; not passed.

Dividend

• No dividend proposed or declared at the AGM.

Director changes

• Proposal to appoint Mr. Shanay Shah as Director not passed.
• Proposal to appoint Mr. Shanay Vikram Shah as Whole-Time Director not passed.

Auditors

• Ratification of remuneration payable to Cost Auditors for the year approved.

Material Related Party Transactions

• No material related party transactions were approved at the AGM.

AGM Details

• Date/time/mode: Sep 10, 2026, 4:00 PM IST, via Video Conferencing.
• Cut-off for voting rights: Sep 3, 2026; remote e-voting Sep 5–9, 2026.
• No physical attendance; proxies not applicable.

Resolutions Presented

• Item 1: Adoption of Audited Standalone and Consolidated Financial Statements.
• Item 2: Ratification of remuneration to Cost Auditors for FY 2026-27.
• Item 3: Appointment of Shanay Vikram Shah as Director.
• Item 4: Appointment of Shanay Vikram Shah as Whole-Time Director for 5 years.

Voting Status

• Item 1: Results to be declared within 48 hours.
• Item 2: Results to be declared within 48 hours.
• Item 3: Results to be declared within 48 hours.
• Item 4: Results to be declared within 48 hours.

Appointments & Auditors

• Director appointment: Shanay Vikram Shah appointed as Director.
• WTD appointment: Shanay Vikram Shah as Whole-Time Director for 5 years.
• Cost Auditor remuneration: Ratification for FY 2026-27.
• Scrutinizer for e-voting: Chintan Patel appointed.

AGM access and annual report

• AGM scheduled: 10 September 2026 at 4:00 PM IST via VC/OAVM.
• Annual Report FY 2025-26 accessible on the company website with AGM notice.
• Letters with AR link sent to members without registered emails.
• AR also disclosed in newspapers and filed with exchanges.
• AR available on BSE and NSE portals.
• Remote e-voting cut-off date: 3 September 2026.

Remote voting and AGM participation

• Remote e-voting starts 5 September 2026 at 9:00 AM IST.
• Remote e-voting ends 9 September 2026 at 5:00 PM IST.
• Members may vote during VC/OAVM if not previously voting remotely.
• Speaker registrations for AGM open until 3 September 2026.

Financial Performance

• Consolidated PBT ₹ 19.7 crores; margin 5.8%; PAT ₹ 10.5 crores; margin 3.1%.
• Net debt approx ₹ 463 crores; gearing 0.46x.

Hospital Segment Update

• Standalone hospital revenue ₹ 259 crores; YoY growth ~7%.
• Standalone EBITDA ₹ 47.8 crores; EBITDA margin 18.4%.
• Standalone PBT ₹ 34 crores; PBT margin 13.1%.
• Standalone PAT ₹ 25 crores; PAT margin 9.7%.
• Beds occupied 701; occupancy 51% (54% including Shalby International).
• ARPOB 44,711; ALOS 3.69 days.
• Payer mix: 30% self-pay, 38% insurance, 32% government.
• Gurgaon revenue ₹ 26.2 crores; ARPOB ₹ 91,326; ALOS 3.8 days; EBITDA break-even.
• International revenue ₹ 13 crores total; Gurgaon ₹ 2 crores; others ₹ 11 crores.
• Transplants: 47 total (41 kidney, 5 liver, 1 bone marrow).

MedTech & International Update

• MedTech consolidated revenue ₹ 47 crores; YoY +53%; QoQ +17%.
• India MedTech revenue ₹ 36 crores; sequential +29%; YoY +98%.
• US MedTech revenue ₹ 38.8 crores; SGTPL ₹ 9.9 million.
• MedTech consolidated EBITDA ₹ 1.7 million; fourth straight quarter positive.
• SMTL India revenue ₹ 22.9 crores; YoY +130%; sequential +191%.
• US EBITDA marginally negative; SGTPL EBITDA ₹ 5.8 million.
• Inventory holding days expected to improve ~30%.
• Q1 FY27 consolidated revenue ₹ 472 million.

Guidance & Outlook

• EBITDA margin to up to 20% for the full year FY27.
• Inventory optimization and working-capital efficiency to continue; selective investments in products/tech.

Q&A Highlights

• Hospital margins: bunkers deployed; new TPA renewals could lift revenue by 5–7%; Gurgaon EBITDA positive; other units growing ~30% YoY.
• Implants bottom line down due to forex; gross margins expected to improve 100–200 bps per quarter; further improvement anticipated.
• DTA recognition: hospital DTA recognized; US MedTech not yet; will reconsider as profitability improves.
• MedTech margins: FX headwinds; India volumes up; cost-reduction plan saves ₹3 crores per month now and another ₹3 crores by Q4; expect double-digit EBITDA margins.
• Shalby International: occupancy ~30% target by Q3/Q4; PBT positive within 6–9 months; 7% EBITDA achieved.

CEO resignation

• Resignation of Deepak Anand as CEO of Shalby MedTech Limited, effective close of business 4 September 2026.
• Reason: moving abroad for personal reasons.
• No other material reasons stated.